|
⚲
|
| Keyboard |
| Kenneth Bate | |
|---|---|
| Firm | |
| Address | 100 High Street 28th Floor Boston, MA 02110 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Catabasis Pharmaceuticals Inc | 021-388817 | Director | 110.0 M of 110.0 M |
||
| Catabasis Pharmaceuticals Inc | 021-388812 | Director | 175.7 M of 175.7 M |
||
| Genocea Biosciences Inc | 021-372378 | Director | 75.5 M of 79.9 M |
||
| Genocea Biosciences Inc | 021-333740 | Director | 12.1 M of 15.0 M |
||
| Madrigal Pharmaceuticals Inc | 021-289979 | Director | 35.0 M of 35.0 M |
||
| Transmedics Inc | 021-247946 | Director | 0.5 M of 0.5 M |
||
| Transmedics Inc | 021-241112 | Director | 20.0 M of 20.0 M |
||
| Catabasis Pharmaceuticals Inc | 021-236973 | Director | 12.4 M of 20.4 M |
||
| Transmedics Inc | 021-197996 | Director | of 30.0 M |
||
| Transmedics Inc | 021-187346 | Director | 36.1 M of 36.1 M |
||
| Transmedics Inc | 021-164439 | Director | 5.9 M of 22.5 M |
||
| Aveo Pharmaceuticals Inc | 021-160532 | Director | 7.5 M of 7.5 M |
||
| Aveo Pharmaceuticals Inc | 021-149990 | Director | 60.8 M of 60.8 M |
||